Endocrine disruptors and human health - Is there a problem? An update

Environmental Health Perspectives

Volumn 108, Issue 6, 2000, Pages 487-493

  Safe, Stephen H ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Endocrine disruptors; Human health; Sperm counts; Xenoestrogens

Indexed keywords

DIETHYLSTILBESTROL; ESTROGEN; ESTROGEN DERIVATIVE; INDUSTRIAL CHEMICAL; ORGANOCHLORINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BREAST CANCER; CANCER INCIDENCE; CONTROLLED STUDY; CRYPTORCHISM; DEMOGRAPHY; DENMARK; ENVIRONMENTAL EXPOSURE; FEMALE; FINLAND; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPOSPADIAS; MALE; MALE FERTILITY; MALE GENITAL SYSTEM DISEASE; MOUSE; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; RAT; REPRODUCTION; REVIEW; SCANDINAVIA; SEMEN ANALYSIS; SPERMATOZOON COUNT; TESTIS CANCER;

ANIMALIA;

EID: 0033939186     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108487     Document Type: Review

References (125)

1. Colborn T, Vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101:378-384 (1993).
2. Giesy JP, Ludwig JP, Tillitt DE. Deformities of birds in the Great Lakes region: assigning causality. Environ Sci Technol 28:128A-135A (1994).
3. Fry DM. Reproductive effects in birds exposed to pesticides and industrial chemicals. Environ Health Perspect 103(suppl 7):165-171 (1995).
4. Sumpter JP, Jobling S. Vitallogenesis as a biomarker for estrogenic contamination of the aquatic environment. Environ Health Perspect 103(suppl 7):173-178 (1995).
5. Guillette LJ Jr, Crain DA, Rooney AA, Pickford DB. Organization versus activation: the role of endocrine-disrupting contaminants (EDCs) during embryonic development in wildlife. Environ Health Perspect 103(suppl 7):157-164 (1995).
6. Birnbaum LS. Developmental effects of dioxin. Environ Health Perspect 103:89-94 (1995).
7. de Solla SR, Bishop CA, Van der Kraak G, Brooks RJ. Impact of organochlorine contamination on levels of sex hormones and external morphology of common snapping turtles (Chelydra serpentina serpentina) in Ontario, Canada. Environ Health Perspect 106:253-260 (1998).
8. Guillette LJ Jr, Pickford DB, Crain DA, Rooney AA, Percival HF. Reduction in penis size and plasma testosterone concentrations in juvenile alligators living in a contaminated environment. Gen Comp Endocrinol 101:32-42 (1956).
9. Guillette LJ Jr, Gross TS, Masson GR, Matter JM, Percival HF, Woodward AR. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect 102:680-688 (1994).
10. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for the decreasing quality of semen during the past 50 years. Br Med J 305:609-612 (1992).
11. Safe S. Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect 103:346-351 (1995).
12. National Research Council. Hormonally Active Agents in the Environment. Washington, DC:National Academy Press, 1999.
13. Vallack HW, Bakker DJ, Brandt I, Broström-Lundén E, Brouwer A, Bull KR, Gough C, Guardans R, Holoubek I, Jansson B, et al. Controlling persistent organic pollutants - what next? Environ Toxicol Pharmacol 6:143-175 (1998).
14. Kutz FW, Wood PH, Bottimore DP. Organochlorine pesticides and polychlorinated biphenyls in human adipose tissue. Rev Environ Contam Toxicol 120:1-82 (1991).
15. Ekbom A, Wicklund-Glynn A, Adami HO. DDT and testicular cancer. Nature 347:553-554 (1936).
16. Tremblay NW, Gilman AP. Human health, the Great Lakes, and environmental pollution: a 1994 perspective. Environ Health Perspect 103(suppl 9):3-5 (1995).
17. Jobling S, Sumpter JP. Detergent components in sewage effluent are weakly oestrogenic to fish: an in vitro study using rainbow trout (Oncorhynchus mykiss) hepatocytes. Aquatic Toxicol 27:361-372 (1993).
18. Nimrod AC, Benson WH. Environmental estrogenic effects of alkylphenol ethoxylates. Crit Rev Toxicol 26:335-364 (1996).
19. Jobling S, Sheahan D, Osborne JA, Matthiessen P, Sumpter JP. Inhibition of testicular growth in rainbow trout (Oncorhynchus mykiss) exposed to estrogenic alkylphenolic chemicals. Environ Toxicol Chem 15:194-202 (1996).
20. Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonylphenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect 92:167-173 (1991).
21. Giger W, Brunner PH, Schaffner C. 4-Nonylphenol in sewage sludge: accumulation of toxic metabolites from nonionic surfactants. Science 225:623-625 (1984).
22. Fairchild WL, Swansburg EO, Arsenault JT, Brown SB. Does an association between pesticide use and subsequent declines in catch of Atlantic salmon (Salmo salar) represent a case of endocrine disruption? Environ Health Perspect 107:349-357 (1999).
23. Routledge EJ, Sheahan D, Desbrow C, Brighty GC, Waldock M, Sumpter JP. Identification of estrogenic chemicals in STW effluent. 2. In vivo responses in trout and roach. Environ Sci Technol 32:1559-1565 (1998).
24. Desbrow C, Routledge EJ, Brighty GC, Sumpter JP, Waldock M. Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environ Sci Technol 32:1549-1558 (1998).
25. Allen Y, Scott AP, Matthiessen P, Haworth S, Thain JE, Feist S. Survey of estrogenic activity in United Kingdom estuarine and coastal waters and its effects on gonadal development of the flounder Platichthys flesus. Environ Toxicol Chem 18:1791-1800 (1999).
26. Gray LE Jr, Kelce WR, Monosson E, Ostby JS, Birnbaum LS. Exposure to TCDD during development permanently alters reproductive function in male Long Evans rats and hamsters: reduced ejaculated and epididymal sperm numbers and sex accessory gland weights in offspring with normal androgenic status. Toxicol Appl Pharmacol 131:108-118 (1995).
27. Gray LE Jr, Ostby JS. In utero 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters reproductive morphology and function in female rat offspring. Toxicol Appl Pharmacol 133:285-294 (1987).
28. Kelce WR, Stone CR, Laws SC, Gray LE. Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature 375:581-586 (1995).
29. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, Van der Saag PT, Van der Burg B, Gustafsson J-Å. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252-4263 (1998).
30. Mably TA, Bjerke DL, Moore RW, Gendron-Fitzpatrick A, Peterson RE. In utero and lactional exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 3. Effects of spermatogenesis and reproductive capability. Toxicol Appl Pharmacol 114:118-126 (1992).
31. Mably TA, Moore RW, Goy RW, Peterson RE. In utero and lactational exposure of male rats to 2,3,7,8-tetra-chlorodibenzo-p-dioxin. 2. Effects on sexual behavior and the regulation of luteinizing hormone secretion in adulthood.Toxicol Appl Pharmacol 114:108-117 (1992).
32. Mably TA, Moore RW, Peterson RE. In utero and lactational exposure of male rats to 2,3,7,6-tetrachlorodibenzo-p-dioxin. 1. Effects on androgenic status. Toxicol Appl Pharmacol 114:97-107 (1992).
33. Mayes BA, McConnell EE, Neal BH, Brunner MJ, Hamilton SB. Sullivan TM, Peters AC, Ryan MJ, Toft JD, Singer AW, et al. Comparative carcinogenicity in Sprague-Dawley rats of the polychlorinated biphenyl mixtures Aroclors 1016, 1242, 1254, and 1260. Toxicol Sci 41:62-76 (1998).
34. Goldberg JM, Falcone T. Effect of diethylstilbestrol on reproductive function. Fertil Steril 72:1-7 (1999).
35. Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect 103(suppl 7):83-87 (1995).
36. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132:2279-2286 (1993).
37. Colerangle JB, Roy D. Profound effects of the weak environmental estrogen-like chemical bisphenol A on the growth of the mammary gland of Noble rats. J Steroid Biochem Mol Biol 60:153-160 (1997).
38. Gould JC, Leonard LS, Maness SC, Wagner BL, Connor K, Zacharewski T, Safe S, McDonnell DP, Gaido KW. Bisphenol A interacts with the estrogen receptor α in a distinct manner from estradiol. Mol Cell Endocrinol 142:203-214 (1998).
39. vom Saal FS, Timms BG, Montano MM, Thayer KA, Nagel SC, Dhar MG, Ganjam VK, Parmigiani S, Welshons WV. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 94:2056-2061 (1997).
40. Nagel SC, vom Saal FS, Thayer KA, Dhar MG, Boechler M, Welshons WV. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect 105:70-76 (1997).
41. Cagen SZ, Waechter JM Jr, Dimond SS, Breslin WJ, Butala JH, Jekat FW, Joiner RL, Shiotsuka RN, Veenstra GE, Harris LR. Normal reproductive organ development in CF-1 mice following prenatal exposure to bisphenol A. Toxicol Sci 50:36-44 (1999).
42. Sharpe RM, Skakkebaek NF. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract Lancet 341:1392-1395 (1993).
43. Sharpe RM. Reproductive biology. Another DDT connection. Nature 375:538-539 (1995).
44. Olsen GW, Bodner KM, Ramlow JM, Ross CE, Lipshultz LI. Have sperm counts been reduced 50 percent in 50 years? A statistical model revisited. Fertil Steril 63:887-893 (1995).
45. Becker S, Berhane K. A meta-analysis of 61 sperm count studies revisited. Fertil Steril 67:1103-1108 (1997).
46. Fisch H, Goluboff ET. Geographic variations in sperm counts: a potential cause of bias in studies of semen quality. Fertil Steril 65:1044-1046 (1996).
47. Swan SH, Elkin EP, Fenster L. Have sperm densities declined? A reanalysis of global trend data. Environ Health Perspect 105:1228-1232 (1998).
48. Lerchl A, Nieschlag E. Decreasing sperm counts? A critical (re)view. Exp Clin Endocrinol Diabetes 104:301-307 (1996).
49. Auger J, Kuntsmann JM, Czyglik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 332:281-285 (1995).
50. Bujan L, Mansat A, Pontonnier F, Mieusset R. Time series analysts of sperm concentration in fertile men in Toulouse, France between 1977 and 1992. Br Med J 312:471-472 (1996).
51. Irvine S, Cawood E, Richardson D, MacDonald E, Aitken J. Evidence of deteriorating semen quality in the United Kingdom: birth cohort study in 577 men in Scotland over 11 years. Br Med J 312:467-471 (1996).
52. Handelsman DJ. Sperm output of healthy men in Australia: magnitude of bias due to self-selected volunteers. Hum Reprod 12:101-105 (1997).
53. Rasmussen PE, Erb K, Westergaard LG. No evidence for decreasing semen quality in four birth cohorts of 1,055 Danish men born between 1950 and 1970. Fertil Steril 68:1059-1069 (1997).
54. Paulsen CA, Berman NG, Wang C. Data from men in greater Seattle area reveals no downward trend in semen quality: further evidence that deterioration of semen quality is not geographically uniform. Fertil Steril 65:1015-1020 (1996).
55. Van Waeleghem K, De Clercq N, Vermeulen L, Schoonjans F, Comhaire F. Deterioration of sperm quality in young healthy Belgian men. Hum Reprod 11:325-329 (1996).
56. Zorn B, Virant-Klun I, Verdenik I, Meden-Vrtovec H. Semen quality changes among 2343 healthy Slovenian men included in an IVF-ET programme from 1983 to 1996. Int J Androl 22:178-183 (1999).
57. Gyllenborg J, Skakkebaek NE, Nielsen NC, Keiding N, Giwercman A. Secular and seasonal changes in semen quality among young Danish men: a statistical analysis of semen samples from 1927 donor candidates during 1977-1995. Int J Androl 22:28-36 (1999).
58. Andolz P, Bielsa MA, Vila J. Evolution of semen quality in North-eastern Spain: a study in 22,759 infertile men over a 36 year period. Hum Reprod 14:731-735 (1999).
59. Fisch H, Goluboff ET, Olson JH, Feldshuh J, Broder SJ, Barad DH. Semen analyses in 1,283 men from the United States over a 25-year period: no decline in quality. Fertil Steril 65:1009-1014 (1996).
60. Saidi JA, Chang DT, Goluboff ET, Bagiella E, Olsen G, Fisch H. Declining sperm counts in the United States? A critical review. J Urol 161:460-462 (1999).
61. Auger J, Jouannet P. Evidence for regional differences of semen quality among fertile French men Hum Reprod 12:740-745 (1997).
62. Zheng Y, Bonde JPE, Ernst E, Mortensen JT, Egense J. Is semen quality related to the year of birth among Danish infertility clients, Int J Epidemiol 26:1289-1297 (1997).
63. Younglai EV, Collins JA, Foster WG. Canadian semen quality: an analysis of sperm density among eleven academic fertility centers. Fertil Steril 70:76-80 (1998).
64. Grocock CA, Charlton HM, Pike MC. Role of the fetal pituitary in cryptorchidism induced by exogenous maternal oestrogen during pregnancy in mice. J Reprod Fertil 83:295-300 (1988).
65. Vorherr H, Messer RH, Vorherr UF, Jordan SW, Kornfeld M. Teratogenesis and carcinogenesis in rat offspring after transplacental and transmammary exposure to diethylstilbestrol. Biochem Pharmacol 28:1865-1877 (1979).
66. Weidner IS, Møller H, Jensen TK, Skakkebæk NE. Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect 106:793-796 (1998).
67. Paulozzi LJ. International trends in rates of hypospadias and cryptorchidism. Environ Health Perspect 107:297-302 (1999).
68. Moss AR, Osmond D, Bacchetti P, Torti FM, Gurgin V. Hormonal risk factors in testicular cancer. A case-control study. Am J Epidemiol 124:39-52 (1986).
69. Schottenfeld D, Warshauer ME, Sherlock S, Zauber AG, Leder M, Payne R. The epidemiology of testicular cancer in young adults. Am J Epidemiol 112:232-246 (1980).
70. Osterlind A. Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943-1982. Br J Cancer 53:501-505 (1986).
71. Bergstrom R, Adami HO, Mohner M, Zatonski W, Storm H, Ekbom A, Tretli S, Teppo L, Akre O, Hakulinen T. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 88:727-733 (1996).
72. Depue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 71:1151-1155 (1983).
73. Cocco P, Benichou J. Mortality from cancer of the male reproductive tract and environmental exposure to the anti-androgen p,p′-dichlorodiphenyldichloroethylene in the United States. Oncology 55:334-339 (1998).
74. Mocarelli P, Brambilla P, Gerthoux PM, Patterson DG Jr, Needham LL. Change in sex ratio with exposure to dioxin [Letter]. Lancet 348:409 (1996).
75. Potashnik G, Goldsmith J, Insler V. Dibromochloropropane-induced reduction of the sex-ratio in man. Andrologia 16:213-218 (1984).
76. De Cock J, Westveer K, Heederik D, Te Velde E, Van Kooij R. Time to pregnancy and occupational exposure to pesticides in fruit growers in The Netherlands. Occup Environ Med 52:429-430 (1994).
77. Marcus M, Kiely J, Xu F, McGeehin M, Jackson R, Sinks T. Changing sex ratio in the United States, 1969-1995. Fertil Steril 70:270-273 (1998).
78. Moller H. Change in male:female ratio among newborn infants in Denmark. Lancet 348:828-829 (1996).
79. Allan BB, Brant R, Seidel JE, Jarrell JF. Declining sex ratios in Canada. Can Med Assoc J 156:37-41 (1997).
80. Davis DL, Gottlieb MB, Stampnitzky JR Reduced ratio of male to female births in several industrial countries: a sentinel health indicator. JAMA 279:1018-1023 (1998).
81. Vartiainen T, Kartovaara L, Tuomisto J. Environmental chemicals and changes in sex ratio: analysis over 250 years in Finland. Environ Health Perspect 107:813-815 (1999).
82. James WH. Was the widespread decline in sex ratios at birth caused by reproductive hazards? Hum Reprod 13:1083-1084 (1938).
83. Akre O, Lipworth L, Tretli S, Linde A, Engstrand L, Adami HO, Melbye M, Andersen A, Ekbom A. Epstein-Barr virus and cytomegalovirus in relation to testicular-cancer risk: a nested case-control study. Int J Cancer 82:1-5 (1999).
84. Wilcox AJ, Baird DD, Weinberg CR, Hornsby PP, Herbst AL Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med 332:1411-1416 (1995).
85. Hemminki E, Gissler M, Merilainen J. Reproductive effects of in utero exposure to estrogen and progestin drugs. Fertil Steril 71:1092-1098 (1998).
86. Falck F, Ricci A, Wolff MS, Godbold J, Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47:143-146 (1992).
87. Wolff MS, Toniolo PG, Leel EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85:648-652 (1993).
88. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372-377 (1993).
89. Bradlow HL, Davis DL, Lin G, Sepkovic D, Tiwari R. Effects of pesticides on the ratio of 16α/2-hydroxy-estrone: a biologic marker of breast cancer risk. Environ Health Perspect 103(suppl 7):147-150 (1995).
90. Silinskas KC, Okey AB. Protection by 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) against mammary tumors and leukemia during prolonged feeding of 7,12-dimethylbenz(a)anthracene to female rats. J Natl Cancer Inst 55:653-657 (1975).
91. Scribner JD, Mottet NK. DDT acceleration of mammary gland tumors induced in the male Sprague-Dawley rat by 2-acetamidophenanthrene. Carcinogenesis 2:1235-1239 (1981).
92. Nesaretnam K, Hales E, Sohail M, Krausz T, Darbre P. 3,3′,4,4′-Tetrachlorobiphenyl (TCB) can enhance DMBA-induced mammary carcinogenesis in the rat. Eur J Cancer 34:389-393 (1998).
93. Ramamoorthy K, Gupta MS, Sun G, McDougal A, Safe SH. 3,3′,4,4′-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary and in human breast cancer cells. Carcinogenesis 20:115-123 (1999).
94. Kociba RJ, Keyes DG, Beger JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Frauson LE, Park CL, Barnard SD, et al. Results of a 2-year chronic toxicity and onco-genicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicol Appl Pharmacol 46:279-353 (1978).
95. Safe S. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol Ther 67 247-281 (1995).
96. Zacharewski T, Safe S. Antiestrogenic activity of TCDD and related compounds. In: Reproductive and Developmental Toxicology (Korach KS, ed). New York:Marcel Dekker, Inc., 1998;431-448.
97. López-Carrillo L, Blair A, López-Cervantes M, Cebrián M, Rueda C, Reyes R, Mohar A, Bravo J. Dichlorodiphenyltrichloroethane serum levels and breast cancer risk: a case-control study from Mexico. Cancer Res 57:3728-3732 (1997).
98. van't Veer P, Lobbezoo IE, Martin-Moreno JM, Guallar E, Gomez-Aracena J, Kardinaal AFM, Kohlmeier L, Martin BC, Strain JJ, Thamm M, et al. DDT (dicophane) and postmenopausal breast cancer in Europe: case control study. Br J Med 315:81-85 (1997).
99. Hunter DJ, Hankinson SE, Laden F, Colditz G, Munson JE, Willett WC, Speizer FE, Wolff MS. Plasma organochlorine levels and the risk of breast cancer. New Engl J Med 337:1253-1258 (1997).
100. Scheeter A, Toniolo P, Dai LC, Thuy LT, Wolff MS Blood levels of DDT and breast cancer risk among women living in the north of Vietnam. Arch Environ Contam Toxicol 33:453-456 (1997).
101. Moysich KB, Ambrosone CB, Vena JE, Shields PG, Mendola P, Kostyniak P, Greizerstein H, Graham S, Marshall JR, Schisterman EF, et al. Environmental organochlorine exposure and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:181-188 (1998).
102. Hoyer AP, Grandjean P, Jorgensen T, Brock JW, Hartvig HB. Organochlorine exposure and risk of breast cancer. Lancet 352:1816-1820 (1998).
103. Guttes S, Failing K, Neumann K, Kleinstein J, Georgii S, Brunn H, Chlororganic pesticides and polychlorinated biphenyls in breast tissue of women with benign and malignant breast disease. Arch Environ Contam Toxicol 35:140-147 (1998).
104. Liljegren G, Hardell L, Lindstrom G, Dahl P, Magnuson A Case-control study on breast cancer and adipose tissue concentrations of congener specific polychlorinated biphenyls, DDE and hexachlorobenzene. Eur J Cancer Prev 7:135-140 (1998).
105. Helzlsouer KJ, Alberg AJ, Huang HY, Hoffman SC, Strickland PT, Brock JW, Burse VW, Needham LL, Bell DA, Lavigne JA, et al. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev 8:525-532 (1999).
106. Moysich KB, Shields PG, Freudenheim JL, Schisterman EF, Vena JE, Kostyniak P, Greizerstein H, Marshall JR, Graham S, Ambrosone CB. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 8:41-44 (1999).
107. Krieger N. Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst 86:589-599 (1994).
108. Zheng T, Holford TR, Mayne ST, Tessari J, Owens PH, Zahm SH, Zhang B, Dubrow R, Ward B, Carter D. et al. Environmental exposure to hexachlorobenzene (HCB) and risk of female breast cancer in Connecticut. Cancer Epidemiol Biomarkers Prev 8:407-411 (1999).
109. Schneider J, Kinne D, Fracchia A, Pierce V, Anderson KE, Bradlow HL, Fishman J. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci USA 79:3047-3051 (1982).
110. Bradlow HL, Telang NT, Sepkovic DW, Osborne MP. 2-Hydroxyestrone: the 'good' estrogen. J Endocrinol 150:S259-S263 (1996).
111. McDougal A, Wilson C, Safe S. Induction of estradiol 2-hydroxylase activity in MCF-7 human breast cancer cells by pesticides and carcinogens. Environ Toxicol Pharmacol 3:195-199 (1997).
112. McDougal A, Safe S. Induction of 16α-/2-hydroxyestrone metabolite ratios in MCF-7 cells by pesticides, carcinogens, and antiestrogens does not predict mammary carcinogens Environ Health Perspect 106:203-206 (1998).
113. Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hämäläinen E. Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst 86:1076-1082 (1994).
114. Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC. A pilot study of urinary estrogen metabolites (16α-OHE1 and 2-OHE 1) in postmenopausal women with and without breast cancer. Environ Health Perspect 105(suppl 3):601-605 (1997).
115. Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC. Urinary 2-hydroxyestrone/16α-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 91:1067-1072 (1999).
116. Gaido K, Dohme L, Wang F, Chen I, Blankvoort B, Ramamoorthy K, Safe S. Comparative estrogenic activity of organochlorine pesticide residues in food and wine extracts. Environ Health Perspect 106:1347-1351 (1998).
117. Bolger M. Unpublished data.
118. Verdeal K, Ryan DS. Naturally-occurring estrogens in plant foodstuffs - a review. J Food Prot 42:577-583 (1979).
119. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 350:23-27 (1997).
120. Morton M, Arisaka O, Miyake A, Evans B. Analysis of phyto-oestrogens by gas chromatography-mass spectrometry. Environ Toxicol Pharmacol 7:221-225 (1999).
121. Stellman SD, Djordjevic MV, Muscat JE, Gong L, Bernstein D, Citron ML, White A, Kemeny M, Busch E, Nafziger AN. Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York. Cancer Epidemiol Biomarkers Prev 7:489-496 (1998).
122. Kurzer MS, Xu X. Dietary phytoestrogens. Annu Rev Nutr 17:353-381 (1997).
123. Tham DM, Gardner CD, Haskell WL. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 83:2223-2235 (1998).
124. Glassner B. The Culture of Fear. New York:Basic Books, 1999.
125. Gyllenborg J, Skakkebaek NE, Nielsen NC, Keiding N, Giwercman A. Secular and seasonal changes in semen quality among young Danish men: a statistical analysis of semen samples from 1927 donor candidates during 1977-1995. Int J Androl 22:28-36 (1999).